• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

bcl-2在肌肉来源的肿瘤中优先表达,但与p53表达无关。

bcl-2 is preferentially expressed in tumours of muscle origin but is not related to p53 expression.

作者信息

Soini Y, Pääkkö P

机构信息

Department of Pathology, University of Oulu, Finland.

出版信息

Histopathology. 1996 Feb;28(2):141-5. doi: 10.1046/j.1365-2559.1996.288334.x.

DOI:10.1046/j.1365-2559.1996.288334.x
PMID:8834522
Abstract

bcl-2 is a proto-oncogene which inhibits apoptosis. In contrast, p53 tumour suppressor gene is known to induce apoptosis. In this study we analysed immunohistochemically 63 mesenchymal tumours for the expression of bcl-2 and p53 proteins with a special emphasis on muscle-derived tumours. bcl-2 was expressed in all seven rhabdomyosarcomas and in five out of seven leiomyosarcomas. In benign muscle tumours, bcl-2 expression was found in all four epithelioid leiomyomas and in six out of 14 leiomyomas. In non-neoplastic muscle cells, occasional weak bcl-2 positivity was found in muscle cells of vascular walls and myometrium. In mesenchymal tumours of other lineages, bcl-2 positivity was only found in four out of 12 malignant fibrous histiocytomas and in one out of three liposarcomas. p53 positivity was found in 14 tumours, 13 of which were sarcomas. No association was found between p53 and bcl-2 positivity. Our results suggest that bcl-2 expression is activated significantly more often in muscle derived tumours than in mesenchymal tumours of other lineages. Our results also suggest that p53 status does not directly affect the expression of bcl-2 in sarcomas.

摘要

bcl-2是一种抑制细胞凋亡的原癌基因。相比之下,已知p53肿瘤抑制基因可诱导细胞凋亡。在本研究中,我们采用免疫组织化学方法分析了63例间叶组织肿瘤中bcl-2和p53蛋白的表达情况,特别关注了肌肉来源的肿瘤。bcl-2在所有7例横纹肌肉瘤以及7例平滑肌肉瘤中的5例中表达。在良性肌肉肿瘤中,所有4例上皮样平滑肌瘤以及14例平滑肌瘤中的6例均发现有bcl-2表达。在非肿瘤性肌肉细胞中,仅在血管壁和子宫肌层的肌肉细胞中偶尔发现弱bcl-2阳性。在其他谱系的间叶组织肿瘤中,仅在12例恶性纤维组织细胞瘤中的4例以及3例脂肪肉瘤中的1例中发现bcl-2阳性。在14例肿瘤中发现p53阳性,其中13例为肉瘤。未发现p53阳性与bcl-2阳性之间存在关联。我们的结果表明,与其他谱系的间叶组织肿瘤相比,bcl-2表达在肌肉来源的肿瘤中更常被显著激活。我们的结果还表明,p53状态并不直接影响肉瘤中bcl-2的表达。

相似文献

1
bcl-2 is preferentially expressed in tumours of muscle origin but is not related to p53 expression.bcl-2在肌肉来源的肿瘤中优先表达,但与p53表达无关。
Histopathology. 1996 Feb;28(2):141-5. doi: 10.1046/j.1365-2559.1996.288334.x.
2
Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.子宫平滑肌肿瘤患者中Bcl-2受体表达:一项比较平滑肌瘤、恶性潜能不确定的子宫平滑肌肿瘤及平滑肌肉瘤的免疫组织化学分析
J Soc Gynecol Investig. 2004 Apr;11(3):187-91. doi: 10.1016/j.jsgi.2003.10.003.
3
p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours.恶性纤维组织细胞瘤及其他间叶组织肿瘤中的p53免疫组织化学
J Pathol. 1992 Sep;168(1):29-33. doi: 10.1002/path.1711680106.
4
Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.与普通平滑肌瘤、平滑肌瘤变体及恶性潜能不确定的平滑肌肿瘤相比,子宫平滑肌肉瘤的特征在于p16、p53和MIB1表达较高。
Histopathology. 2007 Jun;50(7):851-8. doi: 10.1111/j.1365-2559.2007.02699.x.
5
Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours.原发性睾丸生殖细胞肿瘤中p53肿瘤抑制基因和bcl-2癌基因的免疫组织化学及突变分析
APMIS. 1998 Jan;106(1):90-9; discussion 99-100. doi: 10.1111/j.1699-0463.1998.tb01324.x.
6
Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.bcl-2表达在子宫平滑肌肉瘤中的预后意义
Br J Cancer. 1999 Jul;80(10):1658-64. doi: 10.1038/sj.bjc.6690578.
7
Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.Bcl-2在肺神经内分泌肿瘤中的表达:与p53的比较。
J Pathol. 1998 Mar;184(3):247-51. doi: 10.1002/(SICI)1096-9896(199803)184:3<247::AID-PATH994>3.0.CO;2-P.
8
Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?在高危浅表性和浸润性膀胱肿瘤中,p53核过表达、Bcl-2蓄积及增殖细胞核抗原(PCNA)状态是否具有预后意义?
Eur J Surg Oncol. 1999 Feb;25(1):61-5. doi: 10.1053/ejso.1998.0601.
9
Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype.结直肠癌中细胞凋亡以及Bax、Bcl-x和Bcl-2凋亡调节蛋白的表达,及其与p53基因分型/表型的关联
Mol Pathol. 1998 Oct;51(5):254-61. doi: 10.1136/mp.51.5.254.
10
Quantitation of P53 protein expression in gastrointestinal smooth muscle tumors. Clinicopathological correlation and prognostic significance.胃肠道平滑肌肿瘤中P53蛋白表达的定量分析。临床病理相关性及预后意义。
Chin Med J (Engl). 1995 Sep;108(9):669-73.

引用本文的文献

1
Oral alveolar rhabdomyosarcoma: a case report with immunohistochemical analysis.口腔肺泡横纹肌肉瘤:一例免疫组织化学分析病例报告
Clin Pract. 2012 Jan 30;2(1):e17. doi: 10.4081/cp.2012.e17. eCollection 2012 Jan 1.
2
A new scoring system using multiple immunohistochemical markers for diagnosis of uterine smooth muscle tumors.一种使用多种免疫组织化学标志物诊断子宫平滑肌肿瘤的新评分系统。
J Cell Mol Med. 2006 Jan-Mar;10(1):197-205. doi: 10.1111/j.1582-4934.2006.tb00300.x.